People

Benjamin A. Belinka Jr.

sec.gov

Benjamin A. Belinka Jr. is identified as Durin’s chief executive in the2019 and2021 SEC filings and January2023 amendment. The2011 original research paper discloses his salaried executive and stock ownership. Subsequent issuer and SEC disclosures identify different chief executives; this is a historical affiliation, not current post-acquisition leadership.

Roles

Durin Life Sciences

Chief Executive Officer (historical:2019–January2023 SEC filings)

Current